Frédéric Champavere joins The Triana Group, Inc. as Managing Partner Europe

About Frédéric Champavere
Frederic brings to Triana over thirty years experience in the pharmaceutical industry in various positions including diverse geographical responsibilities (both single and multi country), functional (at Corporate Head Office in the USA), operational and entrepreneurial as well as his charismatic leadership. Prior to joining Triana, Frederic was President of the French pharmaceutical company Negma following the acquisition by the Wockhardt Group of India and held responsabilities for continental Europe. Prior to that, he founded Pharma Omnium for which he raised €100 million with the investment fund Weinberg Capital Partners and acquired Biodim. Before going to the venture world, Frederic had an extensive experience with Big Pharma as he started his career at Eli Lilly & Company and over 18 years held several management positions in France, Europe and in the USA and drove Prozac success into the French market as President of Eli Lilly France. He then served as President of Janssen-Cilag France, the main affiliate of Johnson and Johnson in France. During this tenure, Frederic also served for several years as President of Agipharm, the French Local American Working Group. Frederic is a graduate from Science-Po in Paris where he also completed his Masters in Economics and Finance.

About Triana
Triana has founded a business incubator based in NYC (TRIANA LABS) that facilitates US market entry for European small and midsized companies. In exchange of membership fee, cost-plus coverage of resources, royalties and selectively equity, Triana provides one-stop-shop solutions reducing risks and costs while increasing chances to reach success and profitability rapidly. Triana seeks recognized technologies and products in their original markets that offer strong untapped potential in the US based on a thorough review by a talented panel of experts. Members join because Triana’s approach is pragmatic, result oriented, efficient and flexible. It ranges from feasibility study, initial assessment and strategy/planning advice from executive team and well recognized Advisory Board members, to briefing, training, skill transfer on a scale up or down process, to presentation of potential US partners as well as merger and acquisition and securing seed financing for the US venture. Triana provides its members with shared operational resources including managerial talent, infrastructure, administrative support and a network of key individuals in the industry. Initiator of the FACE conference, Triana has a unique ability to reach and gain support of key influencers bringing considerable value for members. Several companies are already benefiting from Triana.